Just a quick update, we attended a meeting in January with the Commission on Human Medicines (CHM) and are now awaiting the outcome of their review into clozapine blood monitoring. We expect to hear the results around June.

Our work is far from over and we will continue to campaign on the wider priorities we’ve highlighted, particularly the need for improved education, training and guidance.

Thank you, as always, for your continued support.  Please help us by sharing our campaign and raising awareness.